Centanafadine In Adults With Attention-Deficit Hyperactivity Disorder |
2024-006-B |
49 |
Transcranial Photobiomodulation Helmet For Motor Signs Of Parkinson’s Disease |
2024-005-B |
45 |
Toludesvenlafaxine Hydrochloride (Ly03005) For Major Depressive Disorder |
2024-003-B |
38 |
Etrasimod for Ulcerative Colitis |
2024-002-B |
31 |
Misha Knee System For Mild-To-Moderate Medial Knee Osteoarthritis |
2024-001-B |
36 |
Donanemab In Early Alzheimer’s Disease |
2023-008-B |
51 |
GB-0998 For Unexplained Recurrent Miscarriage |
2023-005-S |
40 |
Airway Shield |
2023-004-S |
37 |
Capivasertib For Breast Cancer |
2023-002-B |
35 |
Baxdrostat In Patients With Resistant Hypertension |
2023-001-S |
47 |
Aprocitentan In Patients With Resistant Hypertension |
2023-001-B |
38 |
Tirzepatide For Treatment Of Obesity |
2022-010-S |
55 |
Oral Medication For Treatment Of Obstructive Sleep Apnoea |
2022-010-B |
37 |
The Mirvie RNA Platform For Early Detection Of Pre-Eclampsia |
2022-009-S |
36 |
GammaSense for Alzheimer's disease |
2022-009-B |
37 |
Extravascular Implantable Cardioverter-Defibrillator |
2022-008-B |
47 |
Obefazimod (ABX464) For The Treatment Of Ulcerative Colitis |
2022-007-B |
33 |
Nirsevimab For Prevention Of Respiratory Syncytial Virus In Infants |
2022-006-B |
37 |
Etrolizumab For Inflammatory Bowel Disease |
2022-005-S |
34 |
Rewalk Reboot Soft Exoskeleton Device In Stroke Paraplegia Patients |
2022-005-B |
32 |
